Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Clinical trial NCT04382586 · COMPLETED

Trial details

NCT number: NCT04382586
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pulmonary Complications COVID-19

Start date: 2020-07-06
Primary completion: 2021-02-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.